January - March 2020 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting ...
Bridion (sugammadex) injection Arteriospasm coronary (coronary vasospasm) The “Adverse Reactions” section of the labeling was updated in January 2021 to include coronary spasm. Bridion labeling Bydureon (exenatide) Bydureon BCise (exenatide) Byetta ( …